BNP Paribas’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Sell
1,793
-664
-27% -$281K 0.02% 175
2026
Q1
$1.16M Sell
2,457
-12
-0.5% -$6.04K 0.04% 169
2025
Q4
$1.15M Buy
2,469
+126
+5% +$58.5K 0.03% 174
2025
Q3
$999K Sell
2,343
-44
-2% -$17.1K 0.03% 163
2025
Q2
$914K Sell
2,387
-251
-10% -$90.4K 0.03% 174
2025
Q1
$912K Sell
2,638
-237
-8% -$76.2K 0.04% 176
2024
Q4
$863K Buy
2,875
+105
+4% +$36.7K 0.01% 185
2024
Q3
$1.13M Buy
2,770
+456
+20% +$167K 0.05% 149
2024
Q2
$743K Buy
2,314
+1,345
+139% +$437K 0.04% 173
2024
Q1
$323K Buy
+969
New +$296K 0.02% 220

Other funds holding HCA

BNP Paribas's HCA Position: Q2 2026 in Review

BNP Paribas reduced its HCA Healthcare (HCA) stake by 27% in Q2 2026, selling an estimated $281K and leaving 1,793 shares worth $699K. The position accounts for 0.02% of the portfolio, ranked #175.

BNP Paribas first reported a position in HCA in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.16M in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • BNP Paribas held 1,793 shares of HCA Healthcare worth $699K as of Q2 2026.
  • BNP Paribas sold 664 HCA Healthcare shares in Q2 2026, an estimated $281K.
  • HCA Healthcare made up 0.02% of BNP Paribas's portfolio in Q2 2026, its #175 holding.
  • BNP Paribas first reported a position in HCA Healthcare in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas's HCA Healthcare position peaked at $1.16M in Q1 2026.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.